Ontology type: schema:ScholarlyArticle
2003-03
AUTHORSRobert I. Nicholson, Julia M.W. Gee, Janice Knowlden, Richard McClelland, Tracie-Ann Madden, Denise Barrow, Iain Hutcheson
ABSTRACTMany estrogen receptor-positive breast cancer patients initially respond to treatment with antihormonal agents such as tamoxifen, but remissions are often followed by acquisition of resistance and ultimately disease relapse. The development of a rationale for the effective treatment of tamoxifen-resistant breast cancer requires an understanding of the complex signal transduction mechanisms that contribute towards loss of antiestrogen response. Interactions between estrogen and growth factor signaling pathways have been identified in estrogen-responsive cells that are thought to reinforce their individual cellular effects on growth and gene responses. Increasing evidence indicates that abnormalities occurring in growth factor signaling pathways, notably the epidermal growth factor receptor (EGFR) signaling pathway, could dramatically influence steroid hormone action and may be critical to antihormonal-resistant breast cancer cell growth. Thus, inhibitory agents targeting growth factor receptors, or their intracellular pathway components, may prove clinically beneficial in antihormone refractory disease. One example, gefitinib ('Iressa', ZD1839), an EGFR-tyrosine kinase inhibitor, is an interesting therapeutic option that may provide benefit in the treatment of antihormonal-resistant breast cancer. Rapid progress with pharmacological and molecular therapeutic agents is now being made. Therapies that target growth factor signaling pathways may prevent development of resistance. More... »
PAGES29-34
http://scigraph.springernature.com/pub.10.1023/a:1025467500433
DOIhttp://dx.doi.org/10.1023/a:1025467500433
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1034197538
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/14535532
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antineoplastic Agents, Hormonal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Breast Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Drug Resistance, Neoplasm",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm Recurrence, Local",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Protein-Tyrosine Kinases",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Quinazolines",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Receptor, Epidermal Growth Factor",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Signal Transduction",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Nicholson",
"givenName": "Robert I.",
"id": "sg:person.0670333460.58",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670333460.58"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Gee",
"givenName": "Julia M.W.",
"id": "sg:person.012457220672.07",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012457220672.07"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Knowlden",
"givenName": "Janice",
"id": "sg:person.01211220110.63",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211220110.63"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "McClelland",
"givenName": "Richard",
"id": "sg:person.01015772611.79",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015772611.79"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Madden",
"givenName": "Tracie-Ann",
"id": "sg:person.011254553101.43",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011254553101.43"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Barrow",
"givenName": "Denise",
"id": "sg:person.01277511160.33",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277511160.33"
],
"type": "Person"
},
{
"affiliation": {
"name": [
"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff, UK"
],
"type": "Organization"
},
"familyName": "Hutcheson",
"givenName": "Iain",
"id": "sg:person.01143104710.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143104710.88"
],
"type": "Person"
}
],
"citation": [
{
"id": "https://doi.org/10.1073/pnas.93.21.12002",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1014347773"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0092-8674(00)81683-9",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1031899717"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1074/jbc.m006741200",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038339549"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.0.0080175",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038939244"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.0.0080175",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038939244"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.0.0020115",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1043230833"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1016/s0959-8049(01)81461-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047375048"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1054/bjoc.1999.0954",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1048055616",
"https://doi.org/10.1054/bjoc.1999.0954"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.0.0060373",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049227839"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1677/erc.0.0060373",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1049227839"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00666156",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050608312",
"https://doi.org/10.1007/bf00666156"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/bf00666156",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1050608312",
"https://doi.org/10.1007/bf00666156"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2002.03.038",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064202951"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2002.03.100",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064202963"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1200/jco.2002.10.112",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064203155"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1210/endo.137.7.8770893",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064281009"
],
"type": "CreativeWork"
},
{
"id": "https://doi.org/10.1210/endo.142.7.8259",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1064284455"
],
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1074813252",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1075021184",
"type": "CreativeWork"
},
{
"id": "https://app.dimensions.ai/details/publication/pub.1077954228",
"type": "CreativeWork"
}
],
"datePublished": "2003-03",
"datePublishedReg": "2003-03-01",
"description": "Many estrogen receptor-positive breast cancer patients initially respond to treatment with antihormonal agents such as tamoxifen, but remissions are often followed by acquisition of resistance and ultimately disease relapse. The development of a rationale for the effective treatment of tamoxifen-resistant breast cancer requires an understanding of the complex signal transduction mechanisms that contribute towards loss of antiestrogen response. Interactions between estrogen and growth factor signaling pathways have been identified in estrogen-responsive cells that are thought to reinforce their individual cellular effects on growth and gene responses. Increasing evidence indicates that abnormalities occurring in growth factor signaling pathways, notably the epidermal growth factor receptor (EGFR) signaling pathway, could dramatically influence steroid hormone action and may be critical to antihormonal-resistant breast cancer cell growth. Thus, inhibitory agents targeting growth factor receptors, or their intracellular pathway components, may prove clinically beneficial in antihormone refractory disease. One example, gefitinib ('Iressa', ZD1839), an EGFR-tyrosine kinase inhibitor, is an interesting therapeutic option that may provide benefit in the treatment of antihormonal-resistant breast cancer. Rapid progress with pharmacological and molecular therapeutic agents is now being made. Therapies that target growth factor signaling pathways may prevent development of resistance.",
"genre": "research_article",
"id": "sg:pub.10.1023/a:1025467500433",
"inLanguage": [
"en"
],
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1092777",
"issn": [
"0167-6806",
"1573-7217"
],
"name": "Breast Cancer Research and Treatment",
"type": "Periodical"
},
{
"issueNumber": "Suppl 1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "80"
}
],
"name": "The Biology of Antihormone Failure in Breast Cancer",
"pagination": "29-34",
"productId": [
{
"name": "readcube_id",
"type": "PropertyValue",
"value": [
"a2e7e651310939feed00c9b4f6700002a3be2082094e7a27ae77eea0cfbc6714"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"14535532"
]
},
{
"name": "nlm_unique_id",
"type": "PropertyValue",
"value": [
"8111104"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1023/a:1025467500433"
]
},
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1034197538"
]
}
],
"sameAs": [
"https://doi.org/10.1023/a:1025467500433",
"https://app.dimensions.ai/details/publication/pub.1034197538"
],
"sdDataset": "articles",
"sdDatePublished": "2019-04-11T00:14",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000506.jsonl",
"type": "ScholarlyArticle",
"url": "http://link.springer.com/10.1023%2FA%3A1025467500433"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1025467500433'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1025467500433'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1025467500433'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1025467500433'
This table displays all metadata directly associated to this object as RDF triples.
212 TRIPLES
21 PREDICATES
56 URIs
31 LITERALS
19 BLANK NODES